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Abstract 
Pharmaceutical residues can reach agricultural land through amendment with animal or 
human waste. Since 2010, a series of replicated plots received annual applications of 
ivermectin, monensin and zinc bacitracin, either singly or in a mixture, at 0.1 mg/kg and 10 
mg/kg concentrations. I collected soil samples before and after the fourth annual application 
of pharmaceuticals and assayed them for functional changes and amoA gene abundance, a 
gene needed for ammonia oxidation. In 2013, I exposed the soils to 100 mg/kg in a 
laboratory experiment which resulted in acceleration of nitrification. Under 10 mg/kg 
treatments in the field the abundance of ammonia-oxidizing bacteria was suppressed, while 
ammonia-oxidizing archaea increased, suggesting that bacteria are more sensitive to these 
pharmaceuticals, and that archaea can expand to occupy the partially vacated niche. None of 
the pharmaceuticals at the guideline level of 0.1 mg/kg had any effect on soil function or 
ammonia oxidizing organisms. 
Keywords 
Nitrification, ammonia oxidizing organisms, soil, agriculture, pharmaceuticals, 
Environmental Risk Assessment (ERA). 
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1. Introduction 
 
1.1. Soil:  composition and function  
 
Soils have specific physical and chemical characteristics, such as particle size and 
composition, organic matter content, diffused gases (e.g. O2 and CO2), pH, temperature, 
and water content (Tate III 2000). The combination of these factors can create favorable 
or adverse conditions for life. Unfavorable conditions can prevent plant life, however 
even small amount of nutrient allows for microbial growth. Microorganisms are very 
good at adapting their environments to their needs, and  can modify the physical and 
chemical properties of soil, making it possible for them to thrive under conditions that 
would be stressful for other life forms, including plants (Paul and Clark 1989). 
Soil is organized vertically in layers, called horizons, with the top layer generally 
being the most recent, while deeper layers represent further past (Tate III 2000). The 
most studied layers are the “O” (top organic layer, most pronounced in forest soils due to 
accumulating leaves and foliage), “A”, and “B” layers (underneath). The “A” layer 
houses the greatest diversity and abundance of soil dwelling macro- and microorganisms, 
which decline in the “B” layer (Tate III 2000). Most non-forest soils have little organic 
matter present (>5%), and carbon and nitrogen are present in their mineral form; they are 
called mineral soils because of this high mineral content (Tate III 2000). Mineral soils 
can be classified based on the size of soil particles (sand, silt, clay), which facilitates 
inter-study comparisons (Soil textural triangle, http://www.nrcs.usda.gov).  Most soils in 
Southwestern Ontario, Canada originated from material deposited during last glacial 
retreat, and contains high proportion of mineral matter (Tate III 2000). The majority of 
the land in this region has been used for agricultural purposes.  
The physical and chemical elements of soil are modified by the biota present, which 
promotes community growth and development, resulting in the formation of 
interconnected trophic networks (Scharriba et al. 2012). Soil contains macro- (>2mm), 
meso- (0.1-2mm) and microorganisms (<0.1mm) which contribute to soil physical 
structure and function (Griffiths 1965). The total number of microorganisms living in soil 
is not known, but it is estimated at 40 million cells per gram forest soil  (Whitman et al. 
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1998). All soil dwelling organisms contribute to soil functions such as decomposition of 
organic matter and nutrient turnover (Griffiths 1964). Soil macroorganisms include small 
soil dwelling animals such as earthworms, millipedes, beetles, and ants, that move 
through the soil column and mix it while they graze on microorganisms or 
mesoorganisms (Paul and Clark 1989). Mesoorganisms such as Collembola, mites, and 
nematodes migrate through soil feeding on decaying matter and microorganisms. Their 
movement disturbs soil particles, it may expose new nutrients and allows gases and water 
to mix in the soil column. Microorganisms can take advantage of these new conditions to 
proliferate. Bacteria and fungi are primarily responsible for breaking down dead plant 
matter and other microorganisms are responsible for various steps in nutrient cycling 
(Paul and Clark 1989, Tate III 2000). 
 
1.2. Carbon and nitrogen in soils  
 
Microorganisms in soil are considered the natural agents for human and animal 
organic waste disposal (Paul and Clark 1989), because of their ability to recycle carbon 
(C) and nitrogen (N) bound in organic matter. They break the nitrogen and carbon into 
mineral C and N that can enter the soil nutrient pool, which is very important for 
microorganism proliferation and plant growth. Together with carbon, other nutrients and 
trace minerals are released during decomposition for use by soil organisms and plants.  
Carbon exists in the gaseous form in the air (as CO2), and is incorporated into the 
soil ecosystem through CO2 uptake by plants and bacteria (Hutchinson et al. 2007) and 
subsequent incorporation (immobilization) into living tissues.  Once carbon is bound in 
the organic form, it remains there until the tissue dies, at which point C is recycled 
through the decomposition of dead tissues by soil decomposing organisms. Carbon can 
be stored in organic form in tissues for extended periods of time, especially if the species 
is long lived one. Even after tissue death, carbon can be trapped in the organic form, due 
to different levels of degradability of plant material (Terry et at. 1979). Materials such as 
starches are readily hydrolyzed and used by soil microorganisms, while molecules like 
cellulose, lignins, and keratins are only partially decomposed (Attiwill 1986, Tate III 
2000) due to their strong molecular bonds.  
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Fungi and bacteria living in the soil are the major contributors to organic matter 
decomposition, and they breakdown organic matter into simpler molecules that are 
accessible to plants and other microorganisms. Dissipation (oxidation of organic matter) 
generates energy that microorganisms use for growth. During the process of energy 
production, soil microorganisms use molecular O2 as an electron acceptor and yield CO2 
and H2O. The amount of CO2 released is proportional to the amount of degraded matter; 
therefore the rate of microbial decomposition is traceable by monitoring the CO2 emitted 
from the soil (Lehmann and Miller 1999). About 70% of plant residue added to soils is 
degraded, while the remainder is incorporated into microbial biomass, or remains 
undegraded (Tate III 2000).  
Nitrogen is abundant in the environment, but most of it exists in the atmosphere in 
the form of nitrogen gas (N2). Itis only accessible to a small number of organisms 
(nitrogen fixing microorganisms), which add it to the nitrogen pool in the soil (Equation 
1). Dead plant matter also contains nitrogen that is released during decomposition. The 
soil nitrogen pool therefore consists of nitrogen from N2 fixation and N obtained through 
decomposition of plant matter, or in the case of managed agricultural land from fertilizer. 
Decomposers (fungi and bacteria) use tissue-bound N, mineralize it into ammonia (NH3), 
and release it into the soil N pool, making it accessible to other organisms. Ammonia 
present in the soil is converted to ammonium (NH4
+
, the protonated form of ammonia) at 
typical soil pH values. Ammonium is converted to nitrite (first step of nitrification) by 
ammonia-oxidizing organisms. Nitrification is initiated by the insertion of an atom of 
oxygen into ammonia by the ammonia monooxygenase (AMO) enzyme. Further 
oxidation by hydroxylamine oxidoreductase results in nitrite (McTavish et al. 1993, 
Vajrala et al. 2013). Nitrite is quickly converted to nitrate by nitrifying bacteria, and 
readily used by plants. This form is easily converted back to N2 by denitrifying organisms 
(Ellis et al. 1996), or lost to the environment through runoff from the soil surface or 
leaching to the ground water (Friedland et al. 1997). 
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Equation 1. Simplified nitrogen cycle in soil 
 
 
 
1.3. Ammonia oxidizing (AO) organisms 
 
The conversion of soil ammonium to nitrite is catalyzed by a very narrow range of 
organisms called ammonia oxidizers (AO), which use ammonia as their only energy 
source (Stein et al. 2012). The ammonia-oxidizing microorganisms can be distinguished 
from other soil microorganisms through molecular analysis of the amoA genes, which 
encode the ammonia monooxygenase (AMO) enzyme. Two groups of microorganisms in 
soils, bacteria and archaea, possess AMO and are capable of converting NH4
+
 to nitrite 
(Rotthauwe et al. 1997, Francis et al. 2005). Both ammonia oxidizing bacteria (AOB) and 
ammonia oxidizing archaea (AOA) are active in soils. It is well established through amoA 
gene counts in soil that AOA dominate in NH4
+
 limited environments that contain high 
concentrations  of organic nitrogen, while AOB thrive in nitrogen rich ecosystems such 
as agricultural land after fertilizer addition (Stein et al. 2012, Sonthiphand et al. 2013). 
The individual contributions of AOA and AOB to soil nitrification are however largely 
unknown. These organisms are difficult to culture in the laboratory, with only a few 
representatives having been described (Tourna et al. 2008, Martens-Habbena et al. 2009).  
The difficulty in isolating and cultivating these soil microorganisms might be due to their 
diverse nutritional needs, their need for coexistence with other organisms, or other 
conditions that cannot yet be recreated in the laboratory.  
 
1.4. Unmanaged vs. managed (agricultural) soils  
 
Ammonia-oxidizing archaea are usually more abundant than ammonia-oxidizing 
bacteria in cultivated soils (Leininger et al. 2006, Adair and Schwartz 2008, Tourna et al. 
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2008, O'Sullivan et al. 2011, Dias et al. 2012, Taylor et al. 2013). The cultivation of soil 
for crop production creates annual cycles of disturbances that might be responsible for 
the differences between the distributions of AOA and AOB organisms in unmanaged 
versus managed soils. In unmanaged soils, plant and animal remains decompose in situ to 
release nutrients (such as C and N) that other organisms can use. However, in the 
agricultural context, plant residues are rarely returned for decomposition and nutrient 
cycling, and nutrients are exported in the harvested crop. The nitrogen is depleted readily 
and needs to be replenished through fertilization before the next crop is planted (Vitousek 
et al. 1997, Edmeades 2003, Galloway et al. 2004). When inorganic nitrogen fertilizer is 
added to soil, plants and microorganisms compete for that nitrogen (Inselsbacher et al. 
2010). While microorganisms are better than plants at acquiring ammonia in the first 
hours after fertilizer addition, plants are better at holding on to N due to their longer 
turnover rates (Schimel and Bennett 2004). Therefore, the majority of fertilizer applied to 
fields is used by crops and subsequently removed from the site. 
In Ontario it is common practice to apply animal waste (manure) or human waste 
(biosolids) as fertilizer on agricultural fields. The re-use of otherwise wasted material is 
economically important, because it provides a quick and easy way of disposal of farm 
animal and human waste, and it saves landfill space, while providing a source of N to 
crops. The manure and biosolids contain organic nitrogen, which is not readily accessible 
to plants and needs to be mineralized by soil microorganisms into inorganic nitrogen. 
These amendments also contain phosphate and potassium, and they increases soil texture 
and water holding capacity (Eldridge et al. 2008).   
 
1.5. Risk of applying manure and biosolids to agricultural fields 
 
Despite the potential economic gains of using soil amendments, the potential impacts 
of applying waste material to fields need to be carefully considered. The land application 
of municipal biosolids (organic material recycled from sewage) and manures from 
medicated animals introduces veterinary and human pharmaceuticals, endocrine-active 
substances and personal care products into soil (Thiele-Bruhn 2003, Lorenzen et al. 2004, 
Borgmann et al. 2007, Sabourin et al. 2012). In manure, the type and amounts of 
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veterinary pharmaceuticals introduced at the moment of land application varies according 
to what is permitted for use in a given production system, the health status of the animals, 
and how the manure is stored and handled prior to application (Pope et al. 2009). 
Antimicrobial pharmaceuticals are designed to work well in very small concentrations 
on the bacterial and parasitic organisms that attack livestock (Kumar et al. 2005, Toth et 
al. 2011, Jechalke et al. 2014). They are often excreted in their unchanged bioactive 
forms (Al-Ahmad et al. 1999, Thiele-Bruhn 2003, Sarmah et al. 2006), and thus manures 
can contain veterinary pharmaceuticals, including parasiticides and antimicrobial agents 
used for prophylaxis or therapy and for growth promotion (HC 2001, Sarmah et al. 2006, 
Liebig et al. 2010b). Because the majority of the pharmaceuticals excreted by medicated 
animals are still in their active form, they can negatively affect the soil bacteria that come 
in contact with them, with potential negative effects on N processing in soil. Manures 
typically contain pharmaceuticals in combination, and therefore mixture toxicity effects 
are of scientific and regulatory concern (Kemper 2008, van Gestel 2012, Altenburger et 
al. 2013). Among the possible mixture effects (additive, no effect, synergistic) the most 
concern centers on the synergistic effects of these compounds (multiplication of the 
effects of a single pharmaceutical). Singly the pharmaceuticals can be present at levels 
too low to be toxic, but combined and multiplied, the effects can be detrimental to soil 
microorganisms, and their services in soil.  
Pollution with pharmaceuticals can have long term effects on soil organisms, but 
in heavily polluted environments soil microorganisms can become tolerant of the 
pollution, at a community scale (Schmitt et al. 2004). This response is called pollution-
induced community tolerance (PICT) and it results from more tolerant organisms 
multiplying and replacing the more susceptible organisms. This resulted in a change in 
community structure, and sometimes soil function (Nannipieri et al. 2003, Schmitt et al. 
2004, Demoling and Baath 2008, Aaen et al. 2011). The difference between susceptibility 
and tolerance of organisms can be due to intrinsic resistance, ability to tolerate low 
concentrations of pharmaceuticals, structural differences preventing negative effects of 
pharmaceuticals; or acquired resistance through acquiring resistance genes from other 
microorganisms or the environment. In the case of ammonia oxidizing organisms, 
bacteria and archaea are structurally distinct from one another; therefore it is possible that 
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the pharmaceuticals designed to target bacterial infections in farm animals may not 
necessarily affect archaea in the same way. Archaea have a different cell wall structure, 
biochemical pathways, and enzymatic activity from bacteria (Schleper and Nicol 2010) 
although not much is known about the soil achaea due to the difficulty in cultivating the 
organisms (only one soil AOA organisms has been cultivated in the laboratory;  Martens-
Habbena et al. 2009).  
 
1.6. Regulations surrounding use of veterinary pharmaceuticals 
 
The degree to which each new pharmaceutical is tested before approval depends 
on its predicted environmental concentration (PEC). The predicted level of 
pharmaceuticals reaching the environment is tested against a tiered environmental risk 
assessment (ERA), where the no effect concentration level is set as 0.1 ppm (1 parts per 
million is equal to 1 mg pharmaceutical per kg soil). A concentration of 0.1 ppm is the 
International Co-operation on Harmonization of Technical Requirements for Registration 
of Veterinary Medicinal Products (VICH; http://www.vichsec.org) trigger value, and 
indicates the conservative cut-off amount of pharmaceutical in the environment expected 
to cause no detectable negative effects (NOEC = no observable effect concentration) on 
soil organisms or processes (VICH 2000, Montforts 2005, Schmitt et al. 2010) (overview 
of Canadian participation in VICH can be found at http://www.hc-sc.gc.ca/dhp-
mps/vet/legislation/guide-ld/vich/index-eng.php). High loads of pharmaceuticals 
administered to animals can lead to increases in the amount of pharmaceuticals present in 
the manure. 
If the PEC present in the soil treated with manure is below the VICH trigger 
value, no further tests are required for the specified pharmaceutical. However, if the 
amount expected, or already present exceeds 0.1 ppm, it triggers a Phase II of ERA, 
requiring additional soil fate studies on non-target species (Van Den Brink et al. 2005, 
VICH 2005, Tarazona et al. 2010). These are specified one-species tests measuring the 
lethality of the pharmaceutical, taking into account such endpoints as mortality, 
development, and reproduction (species used and corresponding OCED regulations 
summarized in (van Gestel 2012)). Soil incubations (microcosms) measuring functional 
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endpoints (such as mineralization or nitrification) are also used to monitor the microbial 
responses to pharmaceuticals (Van Beelen and Doelman 1997, OECD 2000, ISO 2012). 
The use of soil incubation experiments for functional toxicity studies can be coupled with 
molecular analysis (for example qPCR, quantitive polymerase chain reaction; PCR-
DGGE, PCR based denaturating gradient gel electrophoresis, and others) as an indicator 
of the effects of these pharmaceuticals on the abundance and community structure of soil 
microorganisms (OEHHA 2009). 
 
1.7. Studied pharmaceuticals and their uses 
 
Three pharmaceuticals commonly used to treat farm animals in North America 
that were chosen for my study are monensin (MON), ivermectin (IVER), and zinc 
bacitracin (ZBAC).  All three of these pharmaceuticals have different modes of action, 
and potentially different target organisms in soil (Table 1). Both IVER and MON are 
isolated from soil Streptomyces species (S. avermitilis and S. cinnamoniensis, 
respectively), while ZBAC is isolated from Bacillus species (B. subtilis, and B. 
licheniformis). While IVER and MON have bactericidal properties on their own, ZBAC 
needs to be bound to a metal ion to show bactericidal activity (Ming and Epperson 2002). 
Given that these pharmaceuticals originate from soil dwelling microorganisms, it is 
expected that resistance or tolerance to these compounds already exist at low levels in the 
environment (D'Costa et al. 2011, Bernier and Surette 2013) and this resistance can 
spread under heavy pharmaceutical applications. 
Ivermectin (IVER) is a broad spectrum antiparasitic pharmaceutical, used to kill 
ecto- and endoparasitic infections in sheep, cattle, and pigs. Ivermectin is excreted 
primarily in faeces (Beynon 2012) as a parent (unchanged and active) pharmaceutical 
(Halley et al. 1989, Eržen et al. 2005). A negative effect on non-target invertebrate soil 
species was reported for IVER shortly after its widespread use. The negative effect was 
confirmed during single species toxicity testing in the laboratory and field
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Table 1. Studied pharmaceuticals and their properties 
  Ivermectin Monensin Zinc bacitracin 
  structure 
 
 
 formula C48H74O14 C36H61O11 Na C66H101N17O16Zn 
 
      melting point 155 °C 269°C 250 ºC 
  Solubility 
(solvent) 50 g/L (2-butanone) 50 g/L (methanol) 5.1 g/L (water) 
 action antiparasitic bactericidal bactericidal 
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(Liebig et al. 2010b, O'Hea et al. 2010, Blanckenhorn et al. 2013), where IVER was 
shown to cause mortality (at 5ppm) and reduce reproduction (at 0.02ppm) in soil 
invertebrates (Jensen et al. 2009).  
Monensin (MON) is an ionophore antibiotic (i.e. disrupts ion transport through 
membranes), with antiparasitic properties and it is commonly used in cattle and poultry 
for growth promotion and prevention of bacterial infections.  It is excreted in its active 
form in faeces (Donoho 1984, Sassman and Lee 2007). Following the ban of 
pharmaceuticals as growth promoters in the European Union (UN) in 2006 (EC 2003), its 
use is mainly in North America. MON has reduced reproduction of soil invertebrates, but 
at a much higher level (100ppm) than IVER (Jensen et al. 2009). 
 Zinc bacitracin (ZBAC) is in its biologically active form as a complex of the 
heavy metal zinc and the antibiotic bacitracin (Ming and Epperson 2002). It is used in 
poultry and swine as a growth promoter. It acts by disrupting cell wall synthesis 
(preventing cross linking of peptidoglycans, which are numerous in the cell wall of gram 
positive bacteria but absent in eukaryotic cells). Similar to IVER and NON, it is found in 
its active form in animal manure (Donoso et al. 1970). When zinc is released from 
bacitracin (Drabløs et al. 1999) it can be considered a secondary contaminant in the soil 
treated with ZBAC. Metal pollution was shown to disrupt community function in soils 
with high levels of heavy metals such as copper and zinc (Mertens et al. 2010, Ruyters et 
al. 2013), and it can cause a PICT response in soil communities (Baath et al. 1998). 
 
1.8. Microcosm incubations 
 
Microcosms represent a community, place or situation that represents a miniature 
of something much larger, but encapsulating its characteristic qualities or features. 
Laboratory constructed microcosms are open or closed simplified ecosystems containing 
living organisms assembled in a simplified environment (Huhta 2006). Their function is 
to study processes that drive population and ecosystem ecology, but in a laboratory 
setting, with the intention that the results can then be extrapolated to the outside 
environment. In microcosms one has precise control over abiotic variables, and the 
manipulation of a single parameter is possible, while keeping other factors constant. 
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Microcosms are short term and therefore require less resources; however, due to space 
restrictions they can sometimes over-simplify the natural world, and extrapolation of the 
results therefore can be difficult (Fraser and Keddy 1997, Browder 2004, Drake and 
Kramer 2012). However, the ease of use of these simplified systems makes them useful 
tools for studying natural processes. 
 In studies of pharmaceutical toxicity in soils, microcosms are used to determine 
functional changes. The pharmaceuticals are added to determine the effects they have on 
the measured parameters (Lehmann and Miller 1999, Offre et al. 2009). For 
pharmaceutical dissipation tests, the dissipation of a studied pharmaceutical is monitored 
over time (Girardi et al. 2011).  
 
1.9. Objectives and hypothesis 
 
In the present study, I examined effects of the antiparasitic IVER and the antibiotics 
MON and ZBAC both singly and combination (MIX), using functional assays 
(mineralization and nitrification in soils) and molecular techniques (amoA gene 
abundance and structure of AOA and AOB communities). I hypothesized that the studied 
pharmaceuticals would affect the abundance of soil microorganisms and functions they 
carry out in the soil. Therefore, I predicted that: 1. Increasing exposure concentrations 
(0.1, 10, and 100 ppm) will have an increasingly negative effect on function and AO 
community structure. 2. Pharmaceuticals will cause a negative effect shortly after 
addition to soils, but no long term effect will be present (the community will recover 
from the disturbance, returning to the pre-disturbance levels of function and abundance). 
3. In mixture, single pharmaceutical effects will multiply to exert a synergistic effect on 
the function and structure of soil.  
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2. Materials and Methods 
 
2.1. Chemicals  
 
Methanol, 2-butanone, formamide, IVER, MON sodium salt, and ZBAC salt were 
purchased from Sigma-Aldrich (Toronto, ON). Stock solutions of IVER, MON and 
ZBAC were prepared fresh before addition to soil using 2-butanone, methanol, and sterile 
water, respectively. 
Molecular reagents (PCR, qPCR, and cloning reagents) were purchased from 
Agilent Technologies (Toronto). Primers were ordered from Sigma-Genosys (Toronto), 
and diluted to 10 μM with Tris buffer (Agilent Technologies). TAE buffer, 40% 
acrylamide and urea for DGGE analysis were purchased from BioRad Laboratories 
(Toronto). Radioactively labeled pharmaceuticals for dissipation studies were purchased 
from American Radiolabeled Chemicals, Inc. (ARC, St Louis, MO). 
 
2.2. Long term field experiment (addition of 0.1 and 10 mg/kg of 
pharmaceuticals)  
 
A long term field experiment to evaluate the effects of selected veterinary 
pharmaceuticals on soil properties was undertaken on the Agriculture and Agri-Food 
Canada research farm in London, Ontario (43°01'49.5"N, 81°12'23.8"W). The location 
has a humid continental climate characteristic of much of the mid-Eastern coast of North 
America and loam soils with low organic matter content (2-3%) and pH of 6.9-7.6. In 
2010 the experiment was started, with the plots receiving pharmaceuticals that could 
reach agricultural land through the application of animal manures or municipal biosolids, 
including macrolide antibiotics, fluoroquinonole antibiotics, antiviral pharmaceuticals, 
antimycotic agents, antineoplastic pharmaceuticals, and the pharmaceuticals evaluated in 
the present study (IVER, MON, ZBAC).  
The experimental procedures and field operations are described in Topp et al. 
(2013).  Briefly, a series of plots (2 m
2
, isolated by fiberglass frames) were treated every 
spring since 2010 with two concentrations (0.1 mg/kg and 10 mg/kg) of IVER, MON, or 
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ZBAC, and a mixture (MIX) of all three pharmaceuticals. Each year since 2010, the plots 
have been treated annually in the spring (3 annual treatments applied prior to 2013 
pharmaceutical application). Each treatment had four replicated plots organized in a 
random block design, totaling 40 plots. One kilogram portions of soil were taken from 
each plot, amended in the laboratory with appropriate concentrations of pharmaceuticals 
according to the experimental protocol, brought out to the field, and incorporated into the 
top 15 cm using a mechanized rototiller (sterilized with 70% ethanol between 
treatments). Within 24 h of the pharmaceutical incorporation all plots were seeded with 
soybean (Glycine max, variety: Harosoy). While the actual path the pharmaceuticals 
reach agricultural fields is through  manure application, the manure step was omitted in 
this study to be able to eliminate potential confounding effects due to other chemical and 
microbial constituents in manure. 
 
2.2.1. Soil sampling of field plots 
 
Soils were sampled in May 2013 before the pharmaceutical addition (D0, 
representing a long term effect of 3 years of annual applications of pharmaceuticals), and 
in June 2013 at seven (D7) and thirty (D30) days after the addition of pharmaceuticals. 
Additional sampling to validate the methods was done in fall 2012 (approximately 6 
months following the 2012 pharmaceutical addition to the plots; referred to as “fall” 
throughout this document). 
At each of field sampling times, six soil cores (0-15 cm from the surface) were 
taken from each of the replicate plots with a sterilized (70% ethanol) T-corer and mixed 
together in a polyethylene bags. The samples were brought to the lab, sieved (2 mm 
maximum particle size), and adjusted to 15% moisture with sterile water. The water level 
in the sample was measured using MB45 Ohaus digital moisture analyzer (VWR, 
Toronto, ON). All soils were processed within 24 hours of collection, except the D0 soils, 
which were frozen at -20 ˚C prior to analysis. The sieved and moisture-adjusted field 
soils were used in the microcosm incubation experiment to assess soil function.   
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2.3. Short term laboratory experiment (addition of 100 mg/kg of pharmaceuticals) 
 
Incubations were performed in the laboratory where control soil (i.e. never treated 
with the studied pharmaceuticals) was treated with 100 mg/kg of each pharmaceutical 
and their mixture in triplicate mason jars (500 g soil each). Several kilograms of soil was 
sieved and adjusted to 15% moisture content. Five hundred gram portions of soil were 
dispensed into a series of 1-L glass mason jars and amended with pharmaceuticals as 
follows. Stock solutions were made using 1 mg of pharmaceutical in 10 ml of solvent. 
Approximately one gram of soil was taken from each jar and placed into an aluminum 
foil boat, and 250 µL of stock solution was added to the soil aliquot. The solvent was 
allowed to evaporate for 10 minutes, after which the amended portion was mechanically 
mixed with the rest of the soil for 5 minutes. Mason jars were sealed with a screw-cap lid, 
and incubated at 30 
o
C. Every week the microcosms were opened for 5 minutes to allow 
gas exchange. Seven days following pharmaceutical addition (high D7) half the soil was 
removed from each microcosm for functional analysis and DNA extraction for molecular 
analysis.  Following 30 days of incubation (high D30) the remaining soil was taken and 
the incubation terminated. A scintillation vial containing 10 mL of water was placed in 
each microcosm. Soil not used in experiments was frozen at -20 ⁰C. 
 
2.4. Functional assays 
 
The Organization for Economic Co-operation and Development guidelines 
(OECD 2000) lists mineralization and nitrification as sensitive endpoints for soil toxicity 
testing. Here, mineralization was measured in both the laboratory, using microcosms with 
radioactively labeled plant material (Section 2.4.1), and in the field, using plant-based 
bait lamina strips (Sec. 2.4.2). Nitrification was measured through microcosm incubation 
and analysis of ammonium and nitrate extracted from the soil (Section 2.4.3). In this 
study, microcosms consisted of a mason jar (8 cm diameter, 20 cm high), small jar 
containing soil (4 cm diameter, 4 cm high), and vial of water (scintillation vial containing 
10ml of water) to keep soil from drying. The lid on mason jar was tightly closed to 
eliminate gas exchange with the outside. 
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2.4.1. Rye mineralization  
 
Soils collected from field (fall, D0, D7, and D30) and laboratory (high D7, high 
D30) were mixed with a known amount of 
14C labeled plant material (“rye”, Secale 
cereal) and placed in microcosms. The rye was grown in 2008 in a greenhouse, with 
radiolabeled carbon (
14
CO2), which was incorporated into the plant tissues. The material 
was harvested, dried and chopped, and was stored frozen at -80 °C. The amount of 
radioactivity present in the plant material was determined by oxidation of triplicate 1 g 
portions of the material (Biological Oxidizer OX-500, R.J. Harvey Instrument Co., 
Hillsdale, NJ). 
Rye was mixed with 25 g soil (moist weight) to obtain 1 200 000 Bq per jar of 
soil. Each small jar containing rye spiked soil was placed in a Mason jar with a 
scintillation vial with water and a scintillation vial with an alkali trap (7 mL of 1 M 
sodium hydroxide). The trap was exchanged on days 1, 3, 7, 14, 21, and 28. Ten mL of 
scintillation liquid (“cocktail”, UniverSol™, MP Biomedicals, Montreal, QB) was added 
to each extracted trap, shaken lightly, and counted 24 hours after trap extraction in a LS 
6500 Multi-purpose Scintillation Counter (Beckman Coulter TM, USA).  
The cocktail was needed to allow for counting of the captured radioactivity. 
Namely, the solvent molecules reacted with β particles emitted from radioactive decay of 
14
C to release UV light which, upon absorption by cocktail molecules, emitted blue light, 
which was counted (cpm, counts per minute) with the liquid scintillation counter (LSC). 
The LSC then corrected the cpm values to dpm (disintegrations per minute) based on 
counting efficiency (Auto DMP counting method, one of the options programed into 
LSC). The rate of 
14
C-CO2 production was calculated for each microcosm by plotting 
cumulative 
14
C-CO2 production against microcosm incubation time up to 28 days and 
fitting a curve to the data using Sigma Plot (Version 10, Systat Software Inc., Chicago, 
IL).  
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2.4.2. Bait lamina 
 
To test for a treatment effect on soil faunal activity, an experiment to evaluate the 
decomposition of organic matter was conducted in situ in fall 2012 using bait lamina strip 
tests (Terra Protecta GmbH, Berlin, Germany). The bait lamina strips were 10 cm × 0.5 
cm × 0.01 cm, with 16 perforations spaced 0.5 cm apart and filled with a mixture called 
‘bait’, containing plaster, activated coal and bran flakes (http://www.terra-
protecta.de/englisch/ks-info-en.htm). 
Ten bait strips were inserted vertically in the centre of each control and treated 
plot (40 plots total) in two parallel lines (lines and individual strips spaced 10 cm apart). 
The strips were oriented such that hole #1 was close to the surface, and hole #16 was the 
deepest. To avoid bait loss during insertion, a guide hole was premade in the soil with a 
metal tool of similar dimensions to the lamina strip, prior to the strip insertion.  
The strips remained in the soil for 3 weeks, after which they were carefully pulled 
out. If the soil was wet and obscured the view of the holes, the strip was gently dipped in 
water to remove adhering soil while minimizing loss of the remaining bait (physical 
wiping of the strip with paper towels could have dislodged the bait). The holes were 
scored as active or inactive based on the amount of remaining bait (with bait pierced 
through counted as active). Activity was measured as the total number of pierced holes 
per treatment. 
 
2.4.3. Determination of nitrification potential 
 
One hundred and thirty grams (wet weight) of field soils (fall, D0, D7, D30) and 
laboratory soils (high D7, high D30) were placed in microcosms (see section 2.2.1) and 
incubated at 30 ˚C for 28 days. Subsamples of 15 g (wet weight) were taken out on days 
0, 1, 3, 5, 7, 14, and 28 and extracted for analysis of inorganic nitrogen species (Drury et 
al., 2008). Briefly, 75 mL of 2 M KCl was added to the 15-g soil samples and shaken in 
Nalgene bottles for 1 h on a wrist action shaker (Burrell Scientific, Model 75, Pittsburgh, 
PA) at 385 rpm. Extracts were poured through GF/A grade microfiber filters 
(Whatman™, VWR, Toronto, ON) under vacuum. The supernatants were collected in 
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scintillation vials that were stored at -20 
o
C until colorimetric analysis for ammonium and 
nitrate + nitrite. These nutrient analyses were performed using a SmartChem 140 discrete 
auto-analyzer, (Westco Scientific Instruments, Brookfield, CT). During analysis. nitrate 
was reduced to nitrite by passing it through an open tubular cadmium reductor (OTCR) 
coil, which formed a colored dye upon reaction with N-(naphthyl)-ethylenediamine 
dihydrochloride (SmartChem 140 Method 375-100E-2). The nitrite component present in 
the soil samples was negligible, because nitrite only exists transiently in the soil. 
Ammonium was quantified through reaction with phenol and hypochlorite to form 
indophenol blue (USEPA Method 350.1). 
 
2.5. Molecular methods. 
 
In addition to functional assays, molecular methods were used to examine changes in 
community composition in respect to the different pharmaceutical treatments. Changes in 
total 16S rDNA and amoA genes were monitored. The genes were quantified using 
qualitative methods and visualized using denaturing gradient gel electrophoresis, which 
resolves DNA molecules of equal length on the basis of melting behavior.  
 
2.5.1. DNA extraction 
 
DNA was extracted from 250 mg of soil (wet weight) using the PowerSoil DNA 
extraction kit (MO BIO laboratories, Inc., VWR, Toronto) and quantified with a 
Nanodrop 1000 instrument (ThermoScientific, Toronto, ON). Extracts (corresponding) 
were diluted 10-fold to a final concentration of 1-2 ng DNA/μl with DNAse-free reagent 
water (MO Bio Laboratories, Toronto, ON) and used as template in the PCR. For all of 
the samples, the 10x dilution removed enough inhibitors to allow amplification when 
used in the PCR reaction. Extracted and diluted DNA was stored at -20˚C until analysis.  
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2.5.2. Amplification of DNA 
 
The polymerase chain reaction (PCR) was used for amplification of extracted 
DNA with primers for total 16S rDNA (GM5F/907R, (Muyzer et al. 1993)), AOA 
(Crenamo A23f/Crenamo A616r, (Tourna et al. 2008)) and AOB ((amoA1F/amoA 2R) 
((Rotthauwe et al. 1997)).The 25 μl PCR reaction consisted of 5μl SYBR Green 5x 
buffer, 1.5 μl MgCL2 (200 μM), 0.2 μl of dNTP (25μM), GoTaq Flexi Polymerase 
(Thermo Fisher Scientific, Ottawa, ON), 1 μl of each primer (10 mM) and 2μl of 10 fold 
diluted DNA sample, and remainder filled with molecular grade water. Five microliters 
of PCR product was electrophoretically resolved on 1.5% agarose gel (70 min at 220V), 
and stained with GelRed Nucleic Acid Stain (Cedarlane®, Burlington, ON) to confirm 
the product was of the expected size. The primer information and conditions of the PCR 
reactions are summarized in Table 2.  
 
2.5.3. Quantitative PCR 
 
For quantitative analysis (qPCR) of total 16S rDNA, the BACT2 primer set 
described previously (Suzuki et al. 2000) was used with 2x Brilliant SYBR® qPCR 
Master Mix (Agilent Technologies, Toronto, ON). Reactions contained 12.5 μL buffer, 
0.75uL of each primer (10 mM), 2uL of 10 fold diluted template DNA, and 0.75 μL 
TM1389F probe (HEX-CTTGTACACACCGCCCGTC-BHQ1, HEX: 2′,4′,5′,7′-
tetrachloro-6-carboxy-4,7-dichlorofluorescein succinimidyl ester; BHQ1: Black Hole 
Quencher-1; 10 mM), and molecular grade water for a total of 25uL.  
The abundance of amoA gene for AOA and AOB was determined with the 
following primers: the AOB amoA -specific primers (amoA-1F/amoA-2R) used were the 
same as in the PCR reaction (Rotthauwe et al. 1997). The AOA amoA-specific primers 
(Cre374-F: TAATTGGCGGAACATTGGTT, and Cre495-R: 
CATGTATGGAGGCAATGTCG; Figure 1) were designed and validated in the present 
study as described in Marti et al. (2014). Reactions contained 12.5 μL 2x Brilliant 
SYBR® Green qPCR Master Mix (Agilent Technologies, Toronto, ON), 0.75 uL of  
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Table 2. PCR primer information 
Target Primer pair Conditions Product size (bp) Reference 
Archaeal amoA Crenamo A23f/Crenamo A616r 
95
o
(10min), 95
o
 (45s), 57
o
 (60s), 
72
o
 (45s)x39cycles 
620 
Tourna et al., 
2008 
Bacterial amoA amoA1F/amoA-2R 
95
o
 (10min), 95
o
 (45s), 55
o
 (60s), 
72
o
 (45s)x39cycles 
490 
Rotthauwe 
et al 1997 
16S rDNA GM5F/907R 
95
o
 (10min), 95
o
 (15s), 59
o
 (20s), 
72
o
 (40s)x39cycles 
600 
Muyzer et al 
1993 
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Figure 1. Standard curve for new archaeal amoA primers, Cre374-F/Cre495-R. Cq 
represents the cycle that the amplified DNA reached a threshold quantity (between 0-40 
cycles). The starting quantity corresponds to the known quantity of DNA from the 
standard curve dilutions. 
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each primer (10 mM), and 2 uL of 10 fold diluted template DNA, and molecular grade 
water to bring the volume up to 25 uL. Standard curves were created using 10 fold 
dilutions of plasmid containing 10
6
 to 10
0
 copies per well of archaeal or bacterial amoA 
insert, or 16S rDNA insert. The plasmid was prepared by cloning PCR products into 
competent E.coli cells using the StrataClone cloning kit (Agilent Technologies, Toronto, 
ON), and linearized with NotI-HF™ restriction enzyme (New England BioLabs, Whitby, 
ON). Qualitative PCR conditions and efficiency of the standard curve reactions 
summarized in Table 3. 
Melting curve analysis for amoA targets ranged from 65˚C to 95˚C and was added 
at the end of the 40 cycles, and revealed a single product peak and low primer dimer 
concentrations. Amplifications were performed with a CFX96 Real-Time System 
(BioRad, Toronto, ON) and using the Biorad CFX manager v3.0. Each qPCR sample was 
run in triplicate. Negative controls without DNA template were performed in triplicate 
for each run. The amoA product of the qPCR reaction for the control and high mixture 
treatments at D30 after pharmaceutical addition was sequenced in order to determine the 
relationship between the two communities.  
 
2.5.4. PCR-DGGE method 
 
Denaturing gradient gel electrophoresis (DGGE) analysis used PCR products of 
amoA and 16S rDNA, with one modification: the bacterial forward primer had a 33 base 
pair GC tail (Muyzer et al. 1993) added to the 5’ end. Fifteen microliters of the PCR 
products were loaded directly (without purification) on to 6% polyacrylamide DGGE gel 
(100% denaturing mixture consisted of 7M urea and 40% deionized formamide) of 50-
65%, 55-65%, and 35-50% for 16 rDNA, bacterial amoA and archaeal amoA, 
respectively. Gels were run at 90 V in 60˚C 1xTris acetate EDTA (TAE) buffer for 16 
hours , stained with SYBR Gold (nucleic acid stain, Life Technologies, Burlington, ON) 
and visualized with Molecular Imager Gel Doc
TM
 XR (BioRad, Toronto, ON). Dominant 
bands were cut from the DGGE gel, cloned following a previously described protocol 
(Section 2.3.3.) and sequenced. 
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Table 3. Qualitative PCR primer information 
 
 
 Target Primer pair Conditions Efficiency 
Product 
size (bp) Reference 
Archaeal amoA Cre374-F/Cre495-R 
95
o
 (600s), 95
o
 (15s), 57
o
 
(20s), 72
o
 (40s)x39cycles, 
65-95 melting curve 
97.6 122 this paper 
Bacterial amoA amoA1F/amoA-2R 
95
o
 (600s), 95
o
 (15s), 58
o
 
(20s), 72
o
 (40s)x39cycles, 
65-95 melting curve 
92.9 490 Rotthauwe et al 1997 
Bacterial 16S 
rDNA BACT1369F/PROK1492R 
95
o
 (600s), 95
o
 (15s), 59
o
 
(40s), 72
o
 (40s)x39cycles 109 174 Suzuki et al., 2001 
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2.5.5. Cloning and sequencing of DNA products 
 
The bacterial and archaeal amoA products of the qPCR reaction (control and 10 
mg/kg mixture treatments at D30 after field pharmaceutical addition) were purified 
(QIAquick PCR purification kit, Agilent Technologies, Toronto), and measured using a 
Nanodrop 1000 instrument (ThermoScientific, Toronto, ON). The prepared DNA mix 
was then used in a cloning procedure with competent E.coli cells using a StrataClone 
cloning kit (Agilent Technologies, Toronto, ON). The colonies containing the desired 
insert were picked and amplified to obtain a large quantity of DNA (between 45 and 60 
ng/μL) to be sent for sequencing (Robarts, and on site sequencing). The resulting 
sequences were then analyzed and graphed. 
 
2.6. Pharmaceutical dissipation 
 
Pharmaceutical dissipation experiments were conducted using control soils (never 
treated with pharmaceuticals) that were sieved (2mm) and adjusted to 15% moisture. The 
radioactively labeled pharmaceuticals ivermectin-B1a[24,25-
3
H] (1.85 TBq/mmol in 
ethanol) and monensin [9-
3
H] (185 GBq/mmol) were purchased from American 
Radiolabeled Company (ARC, 99% purity, Saint Louis, MO). The stock solutions were 
diluted with ethanol to make working solutions (6 000 000 Bq per 1mL) before addition 
to soil, and both were stored at -20⁰C. 
 Triplicate small jars containing 50 g of control soil each were supplemented with 
approximately 10,000 dpm/g of ivermectin or monensin. Approximately 1g of soil was 
taken out of the jar onto a foil boat and prepared pharmaceutical solution was added to it. 
The soil was left for 10 min to allow the solvent to evaporate and mechanically mixed 
with the rest of the soil. Small jars containing spiked soil were placed inside mason jars 
and incubated at 30⁰C for 50 days. Microcosms contained a vial of water, but no alkali 
trap, because no radiolabeled CO2 was emitted (tritium compounds do not contain 
radiolabel 
14
C).  
Subsamples (5g of soil) were taken from microcosms on days 1, 3, 7, 21, 35 and 
50, and extracted with methanol three times. Briefly, 15ml of methanol (HPLC grade, 
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Caledon, USA) was added to each 5g sample, shaken for 30 min and centrifuged for 10 
min at 13 000 rpm (Labofuge 6000, Heraeuz Christ) and poured through a filtered funnel 
(0.2 mm). This was repeated two more times. Following the third extraction, the filtrate 
was evaporated under a stream of nitrogen gas, re-suspended in methanol and a 
subsample of this preparation was added to 10ml of cocktail and counted using LS 6500 
Multi-purpose Scintillation Counter (Beckman Instruments, Irvine, CA, USA). The 
generated data were fitted to first order kinetics curve and used to estimate the half-lives 
(time needed for 50% of added substance to dissipate) of the pharmaceuticals.  
Radiolabeled zinc bacitracin was not available; therefore 100 mg/kg of unlabeled 
ZBAC (bacitracin zinc salt, 99% pure, Sigma-Aldrich, Toronto) was added to soil, 
incubated, extracted and analyzed as described above. ZBAC amended soils were 
extracted with multiple solvents (Table 6), and analyzed using LC-MS/MS. However the 
amount of zinc bacitracin in the samples was below detection. A follow-up experiment 
revealed poor solubility of the pharmaceutical in all of the solvents used except the 
phosphate buffer. Zinc bacitracin was suspended in this buffer at 2 and 10 ppm and left in 
for 3 h, and the pharmaceutical was analyzed to confirm that ZBAC could be detected 
through the LC-MS/MS method. LC-MS analysis was performed on a Thermo Q-
Exactive coupled to an Agilent 1290 HPLC system. Samples were run in full scan mode 
to monitor for the parent ion in addition to the use of the MS/MS data for quantification. 
Samples were separated using an Agilent Zorbax eclipse plup C18 RPHD column (2.1 x 
50mm, 1.8 micron) using a water:acetonitrile gradient of 100 to 0 over 5 min at a flow 
rate of 0.3ml/min. The MS parameters were as follows: mass range 100-1000; 35000 
resolution; sheath gas 25; aux gas 15; spray voltage 4.3; capillary temperature 260 
°
C; 
aux gas 425 
°
C.  
 
2.7. Data analysis 
 
All analysis and graphs were done using SigmaPlot (Version 10, Systat Software 
Inc., Chicago, IL). Nitrification rates were estimated on the basis of N accumulated as 
nitrate over the 28-day incubation and calculated as the rate of accumulation per day of 
incubation. Significant differences were established at a significance level of P < 0.05 
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using one way ANOVAs with Holm-Sidak post hoc tests. If data was violating the 
normality or equal variance assumptions of the ANOVA test, a log transformation was 
conducted. For data that were not parametric after log transformation, Kruskal-Wallis 
ANOVAs on ranks were performed followed by Dunn’s post hoc tests.  
The amoA or 16S gene abundance was calculated as the copy number of archaeal 
amoA, bacterial amoA, or 16S rDNA per g soil (wet weight).  Statistically significant 
differences were designated as P < 0.05 using SigmaPlot software (as above) using one 
way ANOVAs with Holm-Sidak post hoc tests. Non-parametric data was log 
transformed, but if the transformation did not improve the variance or normality, 
Kruskal-Wallis ANOVAs on ranks with Dunn’s post hoc tests were performed.  
The intensity of the DGGE bands was not considered as a potential response to 
the treatments, because of an artifact of PCR procedure, that can unequally overestimate 
the high abundance sequences and underestimate or exclude the low abundance 
sequences. Therefore only presence/absence of bands was considered to assess changes in 
AO community structure.  
The resulting sequences were analyzed using BioEdit Sequence Alignment Editor 
(Hall, 1999) and run through the BLAST online search engine to identify the fragments. 
The sequence data were then aligned with ClustalW method using MEGA6 (version 
6.0.5, Tamura 2013). Relationships between sequences were visualized as a phylogenetic 
tree.  
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3. Results  
 
3.1. Long term field experiment 
 
3.1.1. Functional responses 
 
The mineraliztion experiment with bait lamina, conducted six months after the 
2013 pharmaceutical addition, showed no significant differences in activity of 
macroorganisms compared to control (Figure 2). Similatily, no differences  in 
mineralization using radioactiverye were observed at any of the four (fall, D0, D7, and 
D30) sampling times (Table 5).  
There was no significant short term effect on nitrification potential (compared to 
control soil) after the fourth annual application (D7 and D30) or six months after 3 annual 
applications (fall) of each pharmaceutical used singly or in mixture at either of the two 
concentrations (0.1mg/kg and 10mg/kg); however, at D0 (prior to 2013 pharmaceutical 
application, and year after last pharmaceutical addition) the mixture at 10 mg/kg 
concentration increased the nitrification rate (F = 3.4, df = 8, 31, P<0.05; Table 4).  
The ammonium concentration in field soil was low (Table 6) and it rapidly 
depleted during the microcosm incubations, reaching the baseline level (0.1 μg N/g soil) 
within 1-3 days (Appendix 7). The amount of ammonia was significantly higher in 10 
mg/kg ZBAC and MIX treatments seven days after drug addition (H = 22.7, df = 8, 10, 
P<0.05). However the correlation between the nitrification rate and initial ammonia 
concentrations was not significant (Figure 3).  
 
3.1.2. Abundance of total bacteria (qPCR) and community structure 
(DGGE) 
 
There were no differences between the quantities of total bacteria under the 
different pharmaceutical treatments compared to the control soils at any sampling points 
(Figure 4). The structure of the community as per thr DGGE banding pattern also 
revealed no changes in structure (Appendix 1). 
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Table 4. Mean potential nitrification rate (± SD) in soils treated with different concentrations of ivermectin (IVER), monensin 
(MON), zinc bacitracin (ZBAC), and mixture of the 3 (MIX) and incubated for 28 days. For laboratory experiment (100 mg/kg) N=3 
for control and treatment, for field experiment (0.1 and 10 mg/kg) Ncontrol = 8, Ntreatment = 4. 
Treatment  Potential nitrification rate (ng of nitrate + nitrite N accumulated/gram soil/day) 
Days post pharmaceutical application 
concentration pharmaceutical 7 30 180 360 
0 mg/kg CONT 186 ± 20 870 ± 125   N/A     N/A   
100 mg/kg 
IVER 192 ± 44 910 ± 18 
 
N/A 
  
N/A   
MON 281 ± 18 724 ± 32 
 
N/A 
  
N/A   
ZBAC 462 ± 157* 1038 ± 67 
 
N/A 
  
N/A   
MIX 720 ± 33* 948 ± 67   N/A     N/A   
0 mg/kg CONT 771 ± 191 412 ± 72 680 ± 296 622 ± 157 
10 mg/kg 
IVER 731 ± 31 485 ± 33 610 ± 72 785 ± 232 
MON 759 ± 129 403 ± 30 571 ± 115 761 ± 150 
ZBAC 855 ± 167 476 ± 30 541 ± 228 751 ± 69 
MIX 866 ± 75 447 ± 59 485 ± 331 1037 ± 231* 
0.1 mg/kg 
IVER 749 ± 45 410 ± 45 610 ± 24 576 ± 131 
MON 548 ± 209 369 ± 55 544 ± 113 662 ± 178 
ZBAC 561 ± 135 431 ± 126 549 ± 79 809 ± 159 
MIX 756 ± 223 405 ± 30 660 ± 156 803 ± 268 
Note: Asterisks represent significant differences (P<0.05) of the treatment compared to the control soil. N/A means the samples 
were not analysed at that time point. 180 and 360 days corresponds to “fall” and “D0” 
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Figure 2. Bait lamina strip activity (mean ± SD) in field plots six months after pharmaceutical addition ("fall") at two different 
concentrations ("L" = 0.1 mg/kg; "H" = 10 mg/kg) of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), or mixture of the 
3(MIX).Ncontrol = 8, Ntreatment = 4. No significant differences were detected  
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Table 5. Mineralization (mean ± SD) in soils treated with different concentrations of ivermectin (IVER), monensin (MON), zinc 
bacitracin (ZBAC), and mixture of the 3 (MIX) at the end of 28-day incubation with radioactive rye. For laboratory experiment (100 
mg/kg) N=3 for control and treatment, for field experiment (0.1 and 10 mg/kg) Ncontrol = 8, Ntreatment = 4. 
Treatment  Mineralization (% radioactivity recovered after 28 day incubation) 
Days post pharmaceutical application 
concentration pharmaceutical 7 30 180 (fall) 
360 (pre-
application) 
0 mg/kg CONT 36 ± 7 36 ± 3   N/A     N/A   
100 mg/kg 
IVER 31 ± 4 32 ± 3 
 
N/A 
  
N/A   
MON 33 ± 2 28 ± 2 
 
N/A 
  
N/A   
ZBAC 32 ± 2 51 ± 18 
 
N/A 
  
N/A   
MIX 26 ± 3 29 ± 4   N/A     N/A   
0 mg/kg CONT 42 ± 10 38 ± 10 30 ± 8 30 ± 8 
10 mg/kg 
IVER 36 ± 3 38 ± 4 35 ± 16 27 ± 9 
MON 45 ± 3 38 ± 5 47 ± 16 28 ± 4 
ZBAC 33 ± 7 42 ± 6 36 ± 7 32 ± 6 
MIX 32 ± 5 38 ± 3 43 ± 18 29 ± 7 
0.1 mg/kg 
IVER 41 ± 1 34 ± 6 25 ± 10 30 ± 4 
MON 42 ± 3 36 ± 6 27 ± 5 30 ± 4 
ZBAC 34 ± 6 34 ± 4 59 ± 12 39 ± 9 
MIX 40 ± 10 37 ± 8 35 ± 4 31 ± 3 
Note: Asterisks represent significant differences (P<0.05) of the treatment compared to the control soil. N/A means the 
samples were not analysed at that time point. 180 and 360 days corresponds to “fall” and “D0”
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Table 6. Ammonia (mean ± SD) detected in soil samples under different concentrations of ivermectin (IVER), monensin (MON), zinc 
bacitracin (ZBAC), and mixture of the 3 (MIX) measured at the time of soil collection. For laboratory experiment (100 mg/kg) N=3 
for control and treatment, for field experiment (0.1 and 10 mg/kg) Ncontrol = 8, Ntreatment = 4. 
 
Treatment  Ammonia present in soils (ng of ammonia N /gram soil) 
 
Days post pharmaceutical application 
 
concentration pharmaceutical 7 30 180 360 (pre-application) 
 
0 mg/kg CONT 143 ± 88 2791 ± 71   N/A     N/A   
 
100 mg/kg 
IVER 80 ± 62 2894 ± 68 
 
N/A 
  
N/A   
 
MON 3401 ± 432* 2993 ± 100 
 
N/A 
  
N/A   
 
ZBAC 33 ± 4 2966 ± 101 
 
N/A 
  
N/A   
 
MIX 6173 ± 641* 3014 ± 117   N/A     N/A   
 
0 mg/kg CONT 48 ± 42 429 ± 149 3650 ± 1185 1678 ± 149 
 
10 mg/kg 
IVER 160 ± 97 566 ± 58 3519 ± 443 770 ± 58 
 
MON 95 ± 76 537 ± 161 2730 ± 99 2470 ± 161 
 
ZBAC 193 ± 31* 455 ± 294 3677 ± 501 4352 ± 294 
 
MIX 248 ± 22* 542 ± 160 2612 ± 1562 1889 ± 160 
 
0.1 mg/kg 
IVER 86 ± 22 199 ± 105 3361 ± 297 500 ± 221 
 
MON 71 ± 38 542 ± 188 3257 ± 393 1187 ± 1181 
 
ZBAC 52 ± 42 52 ± 96 3343 ± 859 474 ± 161 
 
MIX 115 ± 42 115 ± 96 3662 ± 560 1377 ± 239 
Note: Asterisks represent significant differences (P<0.05) of the treatment compared to the control soil. N/A means the 
samples were not analysed at that time point. 180 and 360 days corresponds to “fall” and “D0”
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Figure 3. Relationship between nitrification potential rate and soil ammonium concentration at the start of the assay, pooling all of the 
data from the field and laboratory experiments. Indicated is the best fit linear regression, which had a coefficient of determination (r
2
) 
of 0.106.
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Figure 4. Abundance of 16S rDNA (mean ± SD) in field soil samples at two different concentrations ("L" = 0.1 mg/kg; "H" = 10 
mg/kg) of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX).Ncontrol = 8, Ntreatment = 4. No 
differences were detected. 
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3.1.3. Abundance and community structure of ammonia oxidizing 
organisms  
 
No long term effects  were seen in the PCR-DGGE profiles of AOA (Appendix 3) 
or AOB (Appendix 4). The DGGE banding pattern for archaea did not change after 
pharmaceutical addition, but bacterial DGGE banding had some differences between 
control and treatments at D30 after pharmaceutical addition. There were also changes in 
amoA copy number in AOA and AOB within 30 days of the treatment with 
pharmaceuticals (Figure 5 and 6). Notably, the quantity of bacterial amoA decreased 
significantly 7 days after receiving any of the pharmaceuticals, or mixture, at the 10 
mg/kg dose (F = 13.3, df = 8, 31, P<0.001; Figure 6), and remained significantly lower 
30 days after application of  ZBAC and MON at 10 mg/kg treatment (H = 25.0, df = 8, 
P<0.001). The archaeal amoA vas not significantly different between control and 
treatments, but increased significantly at D30 for all soils receiving 10 mg/kg (F = 11.1, 
df = 8, 29, P<0.001; Figure 5). Expressed as a ratio, AOA /AOB changed from 0.25 at D0 
to 0.5 at D7 and 2 at D30 with 10mg/kg pharmaceutical addition, reflecting a decrease in 
AOB amoA copy numbers and a subsequent increase of AOA at D30. We saw a 5 fold 
difference between AOA and AOB, with the bacteria remaining as the dominant 
ammonia oxidizer. 
Cloned qPCR products (3 clones from each replicate treatment) at the control and 
high mixture treatment 30 days post pharmaceutical application in the field were 
sequenced and revealed little diversity in archaeal or bacterial sequences (Figure 7 and 8). 
The sequences did not form distinct control-only or mixture-only clades, but were 
intermixed with each other. 
 
3.2. Short term laboratory experiment 
 
3.2.1. Functional responses 
 
Mineralization did not change seven or 30 days after the treatment with 100 
mg/kg concentrations of the studied pharmaceuticals (Table 4). The no-change in this  
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Figure 5. Archaeal amoA copy number (mean ± SD) in field soils at two different concentrations ("L" = 0.1 mg/kg; "H" = 10 mg/kg) 
of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), and mixture of the 3 (MIX). Ncontrol = 8, Ntreatment = 4. Asterisks 
represent treatments that were significantly different (P<0.05) from control.  
 
* 
* * 
* 
35 
 
      
fall D0 D7 D30
C
o
p
y 
o
f 
a
m
o
A
 g
e
n
e
s
 (
c
o
p
y/
g
 s
o
il)
0
4e+5
8e+5
1e+6
2e+6
2e+6
CONTROL 
IVER L 
MON L 
ZBAC L 
MIX L 
IVER H 
MON H 
ZBAC H 
MIX H 
      
Figure 6. Bacterial amoA copy number (mean ± SD) in field soils at two different concentrations ("L" = 0.1 mg/kg; "H" = 10 mg/kg) 
of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX). Ncontrol = 8, Ntreatment = 4. Asterisks 
represent treatments that were significantly different (P<0.05) from control. 
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Figure 7. Relationship of archaeal amoA sequences extracted 30 days after 
pharmaceutical addition in 2013 from control plot (control 1-4, marked with black 
circles) and 10 mg/kg mixture (mix 1-4, marked with white circles). The scale bar 
represents 0.005 nucleotide substitution per 100 nucleotides. 
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Figure 8. Relationship of bacterial amoA sequences extracted 30 days after 
pharmaceutical addition in 2013 from control plot (control 1-4, marked with black 
circles) and 10 mg/kg mixture (mix 1-4, marked with white circles). The scale bar 
represents 0.05 nucleotide substitution per 100 nucleotides. 
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endpoint contrasted with the nitrification rate at 100mg/kg concentration. The 
nitrification was significantly higher in ZBAC and MIX (F = 186.9, df = 4, 10, P<0.001) 
seven days after the pharmaceutical addition, when compared to control. This difference 
was not present at D30. Starting concentrations of ammonia present in soil 7 days after 
pharmaceutical addition was significantly sigher in MON and MIX treatments (F = 
176.1, d = 4, 10, P<0.001), but was depleted fast during the microcosm incubations 
(Appendix 6) and no differences were detected at day 30 after pharmaceutical addition 
(Table 6). 
 
3.2.2. Abundance and community structure of total bacteria and amoA  
 
There was no significant difference between quantity of total bacteria under the 
different treatments (Figure 9), nor was the DGGE banding pattern of 16S rDNA 
different between the treatments and control (Appendix 2). Similarily, DGGE analysis of 
bacterial or archaeal amoA genes showed no difference in community structure between 
the treatments and the control (Appendix 5). There was no detected change in the amoA 
gene copy number 30 days post-application of pharmaceuticals (Figure 10 and 11), but a 
significant increase in amoA under IVER treatmnet was detected at D7 in archaeal 
population (F = 4.7, df = 4, 10, P<0.001).  
 
3.3. Pharmaceutical dissipation 
 
The radioactive analysis of IVER and MON showed that they were degraded 
within one month of application to the soil (IVER t1/2 = 15 days, MON t1/2 = 20 days). 
ZBAC could not be extracted from the soils, and dissolved poorly in most of the solvents 
used (methanol, ethanol. ethyl acetate, acetonitrilie). It was dissolved in potassium buffer 
(what is in it), and detected at 1 and 10 mg/kg concentrations in solution, but extraction 
efficiency from soil was very low (below 10% at D0). It is most likely tightly bound to 
soil particles, and therefore unavailable. 
39 
 
D7 D30
C
o
p
y 
o
f 
1
6
S
 (
c
o
p
y/
g
 s
o
il)
0
1e+6
2e+6
3e+6
4e+6
5e+6
6e+6
CONTROL 
IVER 
MON 
ZBAC 
MIX 
 
Figure 9. Abundance of 16S rDNA (mean ± SD) in laboratory soil samples at two different concentrations ("L" = 0.1 mg/kg; "H" = 10 
mg/kg) of ivermectin (IVER), monensin (MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX). No differences were detected. 
Ncontrol = 3, Ntreatment = 3. No differences were detected. 
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Figure 10. Abundance of archaeal amoA (mean ± SD) in soils treated with 100 mg/kg concentration of ivermectin (IVER), monensin 
(MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX). Ncontrol = 3, Ntreatment = 3. Asterisks represent treatments that were 
significantly different (P<0.05) from control. 
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Figure 11. Abundance of bacterial amoA (mean ± SD)in soils treated with 100 mg/kg concentration of ivermectin (IVER), monensin 
(MON), zinc bacitracin (ZBAC), or mixture of the 3 (MIX).  Ncontrol = 3, Ntreatment = 3. No differences were detected. 
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4. Discussion 
 
The pharmaceutical concentrations of 0.1, 10, and 100 mg/kg soil were chosen to 
encompass a regulatory threshold level that was relevant with respect to expected 
environmental concentrations, through to excessive exposures that are expected to have 
an effect. The 0.1 mg/kg concentration is a cut-off for Tier 1 assessment and is often 
considered below the no observed effect concentration (NOEC), and therefore chosen as 
a guideline and regulatory measure of pharmaceutical concentration. The concentration 
of 10 mg/kg was considered as an effect concentration that will have an impact on 
studied processes, while 100 mg/kg is very high and chosen as an inhibitory 
concentration for this study. 
 
4.1. High pharmaceutical concentration, short term exposure 
 
Under laboratory conditions, an unrealistically high concentration of 
pharmaceuticals was added to the soil to achieve an effect concentration that would affect 
the measured endpoints. The lab experiment increased the concentration of 
pharmaceuticals 10 times from the field exposure and therefore the pharmaceutical 
amount could reach stress or toxic levels able to disrupt soil processes, as shown. Short 
term (up to 30 days) exposure to 100 mg/kg pharmaceuticals affected the functional 
endpoints, but had little impact on 16S rDNA or amoA gene abundance.  
The mixture of pharmaceuticals negatively affected mineralization of radioactive 
rye at 7 days post application compared to the untreated control. This effect was not 
present 30 days after pharmaceutical addition. In contrast to a negative effect on 
mineralization, ZBAC and MIX treatments had a positive effect on nitrogen potential 
rates 7 days after pharmaceutical addition compared to control.  Both MIX and ZBAC 
followed a similar pattern, indicating that zinc bacitracin present in the mixture might be 
the driving force behind the mixture effect in this incubation. As with mineralization, the 
effect was not seen 30 days after pharmaceutical addition, therefore the effects these 
pharmaceuticals exert on soil organisms are short-lived. 
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The fast return to control rates in the mineralization experiment (within 30 days of 
pharmaceutical addition) can be explained by fast pharmaceutical dissipation. For 
example, pharmaceuticals can be inactivated through biodegradation (microbial 
breakdown), photolysis (degradation using light), or sorption to soil (attaching to soil 
particles), all of which decrease pharmaceutical concentrations and limit bioavailability. 
Dissipation rates (expressed as half-lives in this study) of MON were higher than 
previously published values (Carlson and Mabury 2006, Sassman and Lee 2007), 
however some discrepancies between half-lives have been reported. Monensin dissipation 
has varied between 3 and 13 days depending on whether the experiment was carried out 
in the field, or in the laboratory (Yoshida et al. 2010), with field conditions increasing the 
pharmaceutical dissipation rates. In the case of ivermectin, the half-life depended on 
whether the experiment was carried out in the presence of soil microorganisms and light 
(Mougin et al. 2003).   IVER is photodegradable (Mougin et al. 2003), but in the dark 
dissipation relies on microbial dissipation only, and is much slower (21 days compared to 
230 days). The half-life of 15 days found here for IVER was shorter than those 
previously reported (Mougin et al. 2003, Levot 2011). Other factors such as presence of 
manure (Al-Rajab et al. 2009), depth in the soil column (Santoro et al., 2008), or soil type 
(Sabourin et al., 2010) were considered as potential sources of variation on 
pharmaceutical dissipation in the environment. Soil sorption can also be a reason a 
particular pharmaceutical is removed from the soil quickly after its addition, decreasing 
the estimated half-life. However sorption to soil does not always reduce bioavailability 
(Ingerslev and Halling-Sorensen 2000, Thiele-Bruhn 2003). It was shown that adding 20 
mg/kg of ciprofloxacin to soil did not inhibit the mineralization function, because up to 
88% of the pharmaceutical was strongly bound to soil (Girardi et al. 2011). Here, ZBAC 
was strongly attached to soil and assumed to be unavailable to microorganisms, while a 
high recorded extraction rate from faeces (92-93%) was previously reported (Donoso et 
al. 1970, Wicker et al. 1977, Frøyshov et al. 1986). ZBAC was not soluble in tested 
solvents, and only soluble in phosphate buffer at low concentration, therefore its half-life 
could not have been determined. Because the studied pharmaceuticals dissipate rapidly in 
soils (Sarmah et al. 2006, Liebig et al. 2010a), they are active against microorganisms for 
only a short time. Their negative effects were seen at the 100 mg/kg concentration, 
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showing that they are capable of inhibiting microbial processes if added to soil at high 
enough levels.  
Another reason for changes in nitrification occurring at day 7 but not day 30 after 
pharmaceutical addition was nitrogen depletion in the soil.  Ammonium levels were very 
low at the start of the experiment, and other sources of nitrogen had to be available for 
the increased nitrification rate. Antimicrobial bacitracin added to the soil could have 
dissociated from the zinc bacitracin complex and negatively affected sensitive groups of 
microorganisms and released ammonium, which increased the nitrification. Another 
possibility is that heavy metal zinc killed sensitive organisms in soil. Heavy metals can 
select for tolerant species at the expense of sensitive species, resulting in pollution 
induced community tolerance (Schmitt et al. 2006, Fechner et al. 2011). The soil used in 
the experiments had 4.6-5.5 mg Zn/kg soil (A&L Canada Laboratories Inc., Soil test 
report, 2012) in the absence of ZBAC addition. The 100 mg/kg treatment doubled the 
concentration of zinc in soils (adding approximately 4.4 mg of zinc per kg soil). Prior 
exposure to zinc heavy metal (between 30 and 780 mg/kg) has improved rather than 
diminished nitrification in soil (Rusk et al. 2004), while Mertens et al. (2009) showed that 
nitrification is restored to control levels in soil within 2 years of zinc contamination. The 
organisms living in the experimental soil might therefore already have been tolerant to 
zinc prior to the treatment, and thus experienced no negative effect after pharmaceutical 
addition. Initial amount of ammonium in the soil did not correlate well with the increase 
in nitrification rates, and no change in abundance was detected. Therefore, it appears that 
zinc and bacitracin were unlikely to increase soil ammonium-N by killing sensitive 
organisms. 
Another possible reason for the stimulation of nitrification by ZBAC was that 
ZBAC carried sufficient N to increase the nitrification rate. As the only pharmaceutical 
that contained N (16% of compound by MW), it might have stimulated nitrification. 
However, this was unlikely since initial ammonium concentrations were not correlated 
with nitrification rates, indicating that ammonium-N was not rate limiting in the assay. 
Certain microorganisms are able to grow on pharmaceuticals, as was found with under 
long-term application of sulfamethazine (Topp et al. 2013).  
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The decrease in mineralization and increase in nitrification was not accompanied 
by changes in community structure for the 100 mg/kg treatments based on DGGE 
banding profiles using 16S rDNA gene primers, or 16S rDNA gene abundance measured 
by quantitative PCR. Similarly, no differences in bacterial amoA gene copies were seen at 
the concentration of 100 mg/kg at 7 or 30 days after pharmaceutical addition, despite 
observed changes in mineralization and nitrification rates. In a study by Ollivier et al. 
(2013), a single application of sulfamethazine contaminated manure on a field did not 
result in great changes in AOA or AOB abundance, but the second application caused a 
15-fold increase in AOA abundance compared to AOB (Ollivier et al. 2013). Therefore a 
multiyear contamination with 100mg/kg of the studied pharmaceuticals might result in 
changed amoA abundance. However, this high concentration of pharmaceuticals is highly 
unrealistic in the environment.  
Pharmaceutical concentrations found in the field vary with pharmaceutical type, 
persistence and the quantities used in animal productions. For example, topsoil fertilized 
with poultry litter from commercial farms contained 5-183 µg monensin/kg soil (Sun et 
al. 2013). A cumulative PECsoil of 63.4 µg monensin/kg was derived for soil receiving six 
consecutive applications of manure (Hansen et al. 2009) and 50 µg monensin/kg 
following a single application of poultry litter (Žižek et al. 2011). In a study undertaken 
in Nebraska, liquid swine manure contained 320 + 31 mg bacitracin A /kg dry weight 
(Joy et al. 2014). Manure from a pig finishing operation in China contained 51 + 2.3 mg 
bacitracin/kg dry weight (Zhou et al. 2013). In both instances no residues were detected 
in soils treated with these manures, suggesting that ZBAC was sequestered or dissipated.  
Ivermectin can be delivered through injection, pour on and oral drench (Lumaret et al. 
2012).  Ivermectin-treated cattle excreted 0.31 to 0.81 mg ivermectin/kg dung dry weight, 
and pasture soil immediately under dung pats had ivermectin concentrations of up to 
0.085 mg/kg soil dry weight (Römbke et al. 2010). Liebig et al. (2010b) derived a steady 
state (considering dissipation rate and manure application practice) PECsoil of 2.67-6.22 
µg ivermectin/kg soil dry weight for soil receiving manure from weaner pigs (Liebig et 
al. 2010b). Similar to pharmaceuticals, heavy metals can also cause change in community 
composition and microorganism abundance. Under the 100 mg/kg treatment, the soil 
received about 4.4 mg/kg of zinc metal. 
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Laboratory additions of 100 mg/kg increased the concentration of 
pharmaceuticals, changing functional endpoints in soil, therefore validating that these 
pharmaceuticals can cause a negative effect in soils. The change in function was not, 
however, accompanied by changes in 16S rDNA or amoA gene abundance. The 
difference seen could be attributed to the soils being treated with a single application of 
pharmaceuticals, as opposed to the multi-year exposure present in the field. After 
pharmaceutical addition, the soil was incubated in the laboratory at a constant 
temperature, and not exposed to the temperature fluctuations that are present outside 
(Tourna et al. 2008), nor changing day/night cycles, or other environmental factors, like 
rain or frost. Therefore studying toxicity of pharmaceuticals under field conditions needs 
to be considered. 
 
4.2. Intermediate levels of pharmaceuticals 
 
At the intermediate field exposure dose of 10 mg/kg, there was no long term (as 
evaluated in 2012-2013 using pre-application samples) effect on measured endpoints for 
single pharmaceutical exposures, signifying that this level pharmaceutical exposure over 
3 seasons did not disturb soil nitrification. Mixture exposure increased the nitrification 
rate over the long term (one year after application), but not the short term (within 30 days 
of pharmaceutical application). Both the bait lamina study and the radioactive rye 
mineralization experiments showed that single pharmaceuticals or mixture had no 
significant effects on mineralization. These two mineralization experiments tested the 
same soil, but due to soil preparation (moisture adjustment and sieving) prior to the 
radioactive rye addition, some soil dwelling organisms were excluded from that 
experiment.  Specifically, bait lamina strips added to the field soil were exposed to micro-
, meso- and macroorganisms, while the rye incubation soil was sieved to a maximum 
particle size of 2 mm. Therefore the mixture might have had small negative effects on 
soil macroorganisms, but not on meso- or microorganisms.  Short term (within 30 days of 
addition) effects of 10mg/kg pharmaceutical addition to soil did not change the functions 
measured or 16S rDNA gene abundance, but relative abundance of the amoA gene for 
ammonia oxidizing archaea and bacteria changed. Similarly, it was found that tylosin at 
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10 mg/L changed the structure of the bacterial community, but did not change the 
denitrification rate (Roose-Amsaleg et al. 2013), while a shift in community composition 
and a decreased rate of substrate mineralization was detected for tylosin at 50 mg/kg 
(Demoling and Baath 2008). When looking at the responses of agricultural soil 
microorganisms to sulfachloropyridazine, a concentration of only 7.3 mg/kg resulted in 
changes in community composition due to sensitive organisms being replaced by tolerant 
species (Schmitt et al. 2004). 
The difference in the ratio of archaeal to bacterial amoA genes in soils receiving 
any of the pharmaceuticals or mixture at 10 mg/kg was reflective of both an increase in 
AOA abundance (30 days after addition) and decrease in AOB abundance (both 7 and 30 
days after addition). AOB abundance decreased at 7 days post pharmaceutical addition, 
while AOA remained unchanged. The decrease in the abundance of ammonia-oxidizing 
bacteria at D7 with exposure to 10mg/kg, suggests these concentrations were toxic to AO 
bacteria. Because AOA grows faster than AOB (You et al. 2009), bacteria would be at a 
disadvantage. Higher observed susceptibility of AOB to pharmaceuticals compared to 
AOA could be due to structural differences between the two groups. Unlike bacterial cell 
walls, archaeal cell walls do not have peptidoglycan present (Schleper and Nicol 2010), 
and these peptidoglycans are a target for many pharmaceuticals (Khelaifia and Drancourt 
2012). Therefore AOA would be less susceptible to a number of pharmaceuticals. Other 
factors such as light intensity (Merbt et al. 2012), or soil acidity (Gubry-Rangin et al. 
2011) were shown to influence AO archaea. Merbt et al. (2012) showed that under 
constant light (60μE/m2/s), AOA growth was more sensitive that AOB growth, and 
cycles of light and dark were needed for recovery. The molecular analysis of 
representative archaea from soil samples showed clustering into pH dependent clusters, 
where adaptation to different pH was evident (Gubry-Rangin et al. 2011). However in 
present study, the sequences from mixture and control soils did not form distinct 
clustering, but rather the sequences were intermixed suggesting  that the community 
under 10 mg/kg concentration of the mixture did not result in community shift. 
Another possibility for a decrease in AOB abundance is limited NH4
+
, which 
prevents AOB from further growth. The initial growth of ammonia oxidizing bacteria 
would decrease the available ammonium in soil, making the environment less favorable 
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for that group. By day 7 after pharmaceutical addition the amount of extractable 
ammonium in field soils decreased below the limit of detection. Lower nitrogen resources 
would mean AOB numbers would diminish quickly, while the space and released 
nutrients would be available to archaea. AOA have a competitive advantage in nitrogen 
limited environments (Km= 0.132 μM NH4
+
; Martens-Habbena et al. 2009), and often a 
decreasing amount of ammonium corresponds to increasing AOA abundance (Sauder et 
al. 2012), as opposed to high ammonium sites where AOB (Km= 15 μM NH4
+
; Martens-
Habbena et al. 2009) has an advantage (Verhamme et al. 2011). It was noted in multiple 
studies that agricultural soils that receive inorganic N in the form of fertilizer have higher 
abundance of AOB organisms due to nitrogen rich manure addition (Glaser et al. 2010, 
Höfferle et al. 2010, Reed et al. 2010). Similarly, soil used for cattle overwintering with 
heavy animal presence had increased abundance of AOB (Radl et al. 2014).  
With low amounts of N in soil, AOB numbers remained low and the AOA 
numbers increased, presumably due to their ability to thrive in low nitrogen environments 
and utilizing the space released by AOB. The functional redundancy of ammonia 
oxidizing organisms (discussed in Nannipieri et al. 2003) allowed for retained function in 
the soil at 10 mg/kg, despite changing numbers of AOA and AOB, as detected by 
quantitative PCR of the amoA gene.   
 
4.3. Regulatory threshold concentrations 
 
There were no effects of any treatment, either long term (after 3 years of 
applications) or acute (7 and 30 days after application), for the environmentally relevant 
and regulatory concentration of 0.1 mg/kg on any measured functional endpoints. This 
held true for both single pharmaceutical and mixture exposures.  
Pharmaceuticals were most likely applied at sub-inhibitory concentrations 
(NOEC) that did not affect microbial populations, even for the mixture treatment. This 
result could be a side effect of existing resistance pathways, or tolerance mechanisms. 
Natural tolerance to naturally derived antibiotics exists in soils (Thiele-Bruhn 2003, 
D'Costa et al. 2011), especially for soil-derived chemicals. For example, some botanically 
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derived pesticides have no effect on microorganisms, as opposed to synthetics that were 
not derived from nature but created in laboratory (Spyrou et al. 2009).  
 The threshold concentration of 0.1 mg/kg, the cut off for Environmental Risk 
Assessments, is conservative enough not to disrupt soil processes or cause any detectable 
changes in amoA gene abundance or community structure of soil organisms under IVER, 
MON and ZBAC treatments. Based on the current study, the three studied 
pharmaceuticals were dissipated in the soils rapidly, but other pharmaceuticals can be 
persistent in the environment, and accumulate over the years of exposure (Tamtam et al. 
2011, Vazquez-Roig et al. 2012). Therefore, long term dissipation studies of different 
pharmaceuticals in the field should always be carried out, and lab experiments might 
underestimate the long term effect pharmaceuticals can have on soil organisms. 
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Conclusion 
 
At an environmentally reasonable and regulatory threshold concentration of 0.1 
mg/kg, there was no effect of the studied pharmaceuticals on mineralization or 
nitrification, either in the long or short term. This scenario, however, was tested on an 
artificial system, where pharmaceuticals were added to the soil directly in order to control 
the concentrations. Using manure mixed with pharmaceuticals is needed to verify that 
this would happen during normal farming practice.  
Manure acts as a source of nutrients to soil microorganisms and it has sorption 
characteristics (it can bind the pharmaceuticals to the organic matter present in the 
manure) that can make pharmaceuticals bio-unavailable. Therefore adding veterinary 
pharmaceuticals with the manure would potentially decrease any negative effects 
observed in this study. However, number of different pharmaceuticals can be added to the 
soil at once with each manure application, due to multiple veterinary pharmaceuticals 
used in animal production. The mixture of these pharmaceuticals can affect the soil 
microorganisms, where single drug did not. Therefore it is important to measure 
additional endpoints that were beyond the scope of this study. One could look at other 
soil functions (other steps in nitrogen cycle in the soil, or other nutrient cycling), or 
biodiversity (displacement of species, direct counts or molecular analysis) to assess if the 
pharmaceuticals affect other groups of microorganisms or their function.  
It is possible that if our mixture contained more than the 3 studied 
pharmaceuticals at 0.1 mg/kg concentration, it could have an impact on studied functions 
and abundance of ammonia oxidizers, especially bacteria. It is unknown if ammonia 
oxidizing archaea would at all respond to the veterinary pharmaceuticals.  Little is known 
about that group in soil; further study of archaeal physiology from soil-isolated 
microorganisms is needed to understand how they interact with pharmaceuticals in the 
environment. It is essential to get more information about the soil dwelling organisms, 
their function, and how that function in soils is affected by addition of manure containing 
veterinary pharmaceutical. 
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Appendix 1. DGGE images using 16S rDNA primers at D0 (A), D7 (B), D30 (C) and 
fall (D) after field pharmaceutical addition. Line 1 represents the control, lines 2-5 
represent 0.1 mg/kg treatments, and lines 6-9 represent 10 mg/kg treatments. Treatments 
are: 2 , 6 = ivermectin;, 3, 7 = monensin; 4, 8 = zinc bacitracin; 5, 10 = mixture. 
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Appendix 2. DGGE image using 16S rDNA primers and soils treated with 
pharmaceuticals at 100 mg/kg. Images represent soils at D7 (lines 1-5) or D30 (lines 6-
10). Treatments are as follows: 1, 6 = control; 2, 7 = ivermectin; 3, 8 = monensin; 4, 9 = 
zinc bacitracin; 5, 10 = mixture. 
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Appendix 3. DGGE images obtained using archaeal amoA primers at D0 (A), D7 (B), 
D30 (C) and fall (D) after field pharmaceutical addition. Line 1 represents the control, 
lines 2-5 represent 0.1 mg/kg treatments, and lines 6-9 represent 10 mg/kg treatments. 
Treatments are: 2, 6 = ivermectin; 3, 7 = monensin; 4, 8 = zinc bacitracin; 5, 10 = 
mixture. 
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Appendix 4. DGGE images obtained using bacterial amoA primers at D0 (A), D7 (B), 
D30 (C) and fall (D) after field pharmaceutical addition. Line 1 represents the control, 
lines 2-5 represent 0.1 mg/kg treatments, and lines 6-9 represent 10 mg/kg treatments. 
Treatments are: 2, 6 = ivermectin; 3, 7 = monensin; 4, 8 = zinc bacitracin; 5, 10 = 
mixture. 
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Appendix 5. DGGE image obtained using archaeal (A) and bacterial (B) amoA, and soils 
treated with 100 mg/kg of pharmaceuticals. Lines 1-5 represent D7 soil, and lines 6-10 
represent D30 soil. 1, 6 = control, 2, 7 = ivermectin, 3, 8 = monensin, 4, 9 = zinc 
bacitracin, 5, 10 = mixture. 
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Appendix 6. Nitrification potential experiments with soils treated with 100 mg/kg of 
pharmaceuticals. Panels A and B show ammonia utilization, and panels C and D show 
nitrate accumulation. 
D7 soil D7 soil 
D30 soil D30 soil 
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Appendix 7. Nitrification potential experiments in soil treated with 0.1 mg/kg (“L”) or 
10 mg/kg (“H”) of pharmaceuticals. Panels A, B and C represent ammonia utilization, 
while panels D, E and F represent nitrate accumulation. 
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Appendix 8. Summary of performed statistics. 
      ANOVA Kruskal-Wallis ANOVA on ranks 
  experiment type 
sampling 
time F stat df 
P 
value 
Holm-
Sidak 
H 
stat df 
p 
value 
Dunn's 
Method 
field mineralization fall 1.79 8, 29 0.12 ns 
     D0 1.05 8, 30 0.42 ns 
     D7 
    
11.76 8 0.16 ns 
 D30 0.26 8, 29 0.97 ns 
     bait lamina fall 1.59 8, 31 0.17 ns 
     nitrification fall 
    
3.52 8 0.90 ns 
 D0 3.38 8, 31 0.01 * 
     D7    
 
8.28 8 0.41 ns 
 D30 
    
12.09 8 0.15 ns 
 
Ammonia, initial 
concentration 
fall 
    
15.07 8 0.06 ns 
 D0 2.88 8, 29 0.02 ns 
     D7 
    
22.75 8 <0.05 * 
 D30 
    
10.48 8 0.23 ns 
 archaeal amoA 
abundance 
fall 1.85 8, 31 0.11 ns 
     D0 
    
14.79 8 0.06 ns 
 D7 1.14 8, 31 0.37 ns 
     D30 11.10 8, 30 0.02 * 
     bacterial amoA 
abundance 
fall 1.23 8, 30 0.32 ns 
     D0 1.11 8, 28 0.39 ns 
     D7 20.33 8,30 <0.001 * 
      D30 8.62 8, 30 <0.001 *     
laboratory mineralization D7 0.84 4, 10 0.53 ns         
 D30 2.74 4, 10 0.09 ns 
     nitrification D7 186.92 4, 10 <0.001 * 
     D30 
    
18.90 4 0.03 * 
 
Ammonia, initial 
concentration 
D7 176.10 4, 10 <0.001 * 
     D30 1.78 4, 10 0.21 ns 
    
 
archaeal amoA 
abundance 
D7 4.71 4, 10 <0.001 * 
     D30 5.62 4, 10 0.01 * 
    
 
bacterial amoA 
abundance 
D7 0.69 4,10 0.62 ns 
      D30 3.56 4, 10 0.05 ns         
Note. Asterisks represent significant differences (P<0.05) of the treatment compared to the control soil; ns 
means there was no significant differences between treatment and controls.
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